Journal of Neuro-Oncology

Papers
(The TQCC of Journal of Neuro-Oncology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas68
A practical guide to neuro-oncology fellowship58
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence54
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease53
Prognostic factors among patients with brain metastases from cancer of unknown primary site47
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas42
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma42
Factors influencing timely diagnosis in neurolymphomatosis41
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection39
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma35
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review35
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab34
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases33
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population32
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review32
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases32
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma31
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale31
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival31
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor29
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu29
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience28
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline28
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities27
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma27
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update26
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study26
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management25
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival25
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study25
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy24
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis24
Comment on: “Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma”24
Focused versus conventional radiotherapy in spinal oncology: is there any difference in fusion rates and pseudoarthrosis?24
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery23
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review22
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases22
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis22
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma22
Journal of Neuro-Oncology, Meningioma issue21
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp7021
Patterns of response following gamma knife radiosurgery for tectal plate gliomas21
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses21
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 202421
Early and late structural brain changes after radiation therapy: an MRI study in glioma patients21
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis20
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer20
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme20
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection20
The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour19
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice19
Correction to: A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases19
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data19
The concept, intention, and evaluation of the term treatment-refractory meningioma19
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy19
The use of telemedicine in pre-surgical evaluation: a retrospective cohort study of a neurosurgical oncology practice19
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM4419
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients18
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma18
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases18
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases18
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series18
The role of spine stereotactic radiosurgery for patients with breast cancer metastases18
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound18
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience18
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?18
Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey18
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors17
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?17
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors17
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis17
Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study17
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma17
Management and treatment of brain tumors during pregnancy: an Italian survey17
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation17
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control17
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China17
Risk calculator for long-term survival prediction of spinal chordoma versus chondrosarcoma: a nationwide analysis17
The evolving role of reirradiation in the management of recurrent brain tumors17
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence17
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning17
The posterior fossa syndrome questionnaire: using science to inform practice17
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis17
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study17
Repurposing mebendazole against triple-negative breast cancer CNS metastasis16
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator16
The Journal of Neuro-Oncology: the last and next 40 years16
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry16
The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials16
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis16
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity16
IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas16
Comment on “The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management”16
Stereotactic radiosurgery for patients with spinal metastases from prostate cancer16
The state of art of awake craniotomy in Latin American countries: a scoping review16
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis16
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis16
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches16
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update16
Stereotactic radiosurgery ensures an effective and safe long-term control of Koos grade IV vestibular schwannomas: a single-center, retrospective, cohort study16
Diagnostic value of 18F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients16
NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis15
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors15
Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy15
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma15
Radiotherapeutic advances in the management of glioblastoma15
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery15
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway15
Letter to the editor: surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study15
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT15
Preoperative assessment of eloquence in neurosurgery: a systematic review15
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma15
High dose image-guided, intensity modulated radiation therapy (IG-IMRT) for chordomas of the sacrum, mobile spine and skull base: preliminary outcomes15
China National Glioma Registry (CNGR): protocol for a prospective observational registry study15
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression15
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study14
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes14
Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma14
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis14
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors14
Anatomical changes in resection cavity during brain radiotherapy14
Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: a nationwide analysis14
The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary s14
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide14
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws14
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?14
Elevating the findings by substituting in “ISarcoPRM”14
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues13
Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features13
Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway13
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion13
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study13
Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis13
Standardizing connectome-based brain tumor surgery through a network-based surgical nomenclature13
Correction to: Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions13
Palliative care of older glioblastoma patients in neurosurgery13
Survival of nervous system tumors in a Colombian population cancer registry13
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC113
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer13
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF10413
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-044913
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions13
The role of MRI patterns in predicting neurologic deficits in spinal ependymomas13
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study13
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery13
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR)13
Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions13
Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis13
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age13
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery12
Long-term outcomes of modern radiation therapy for pituitary adenoma – different techniques: single institute experience12
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion12
Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: a systematic review and meta-analysis by the Korean Society for Neuro-Oncolo12
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial12
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study12
Racial disparities in the management and outcomes of primary osseous neoplasms of the spine: a SEER analysis12
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review12
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry12
Surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study12
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes12
Correction to: The characteristics of brain structural remodeling in patients with unilateral vestibular schwannoma12
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study12
The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database11
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis11
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort11
Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Rad11
Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma11
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review11
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas11
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients11
Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation11
Impact of seizures and antiseizure medication on survival in patients with glioma11
Long-term outcomes of central neurocytoma – an institutional experience11
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center11
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM11
Comment on “Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients”11
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis11
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response11
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study11
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis11
Regression of sporadic CNS hemangioblastomas with belzutifan11
Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study11
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma11
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients11
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol11
Repeated stereotactic radiosurgery for high grade meningioma11
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma11
Surgical characteristics and survival outcomes of pediatric pineal region tumors: a cohort study in Vietnam10
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience10
Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma?10
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis10
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study10
Tumor-related epilepsy in high-grade glioma: a large series survival analysis10
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis10
Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers10
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations10
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma10
Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification10
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas10
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?10
Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery10
Interstitial photodynamic therapy for newly diagnosed glioblastoma10
Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor10
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center10
Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis10
Meningioma in patients exposed to progestin drugs: results from a real-life screening program10
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up10
Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery10
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI10
The magnitude of surgical site infection and its associated factors among pediatric central nervous system (CNS) tumor patients at tertiary referral hospitals in Ethiopia: a multi-center study10
Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study10
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma10
Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis10
Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous 10
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study10
The patients’ experience of neuroimaging of primary brain tumors: a cross-sectional survey study10
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study10
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience10
The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors10
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment10
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma10
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications10
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates10
Evaluation of clinical and volumetric outcomes following adaptive gamma knife radiosurgery for brain metastases10
Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol9
The role of GammaTile in the treatment of brain tumors: a technical and clinical overview9
Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review9
Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases9
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors9
Mental health status and associated factors of caregivers of patients with malignant brain tumors9
Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma– a retrospective study of 279 meningioma patients9
Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases9
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review9
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles9
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 20189
National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey9
Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas9
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience9
Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level9
Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a9
Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma9
Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results9
MGMT promoter methylation in 1p19q-intact gliomas9
Long-term quality of life and hypothalamic dysfunction after craniopharyngioma9
Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial9
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery9
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 39
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis9
The dynamic nature of frailty in metastatic spine disease patients9
Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)9
0.055027008056641